U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration and the World Health Organization say ivermectin pills — typically used to treat… read on > read on >








-300x200.jpeg)










